Why is Remedium Life falling/rising?

As of 22-Sep, Remedium Lifecare Ltd's stock price is currently at 1.55, reflecting an increase of 0.03 or 1.97%. The stock has shown a positive trend recently, having outperformed its sector by 2.21% today and achieving consecutive gains over the last two days, resulting in a total return of 3.33% during this period. However, despite these short-term gains, the company faces significant challenges, including a high Debt to EBITDA ratio of -1.00 times, indicating a low ability to service debt, and a history of negative financial performance with reported losses over the last four consecutive quarters. The company has also experienced a drastic decline in net sales of -76.36%, contributing to its poor long-term growth prospects.
In the broader market context, the stock has outperformed the Sensex in the short term, with a 1-week return of +1.97% compared to the benchmark's +0.46%. However, the stock has underperformed significantly over the longer term, with a year-to-date decline of -56.63% against the Sensex's +5.15% and a staggering 1-year return of -75.52% compared to the market's -2.82%. This stark contrast highlights the stock's volatility and the risks associated with its current trading position, despite some recent positive movements.